Andersson K-E, Schröder A
Department of Clinical and Experimental Pharmacology, Lund University Hospital, Lund, Sweden.
Urologe A. 2004 May;43(5):552-6. doi: 10.1007/s00120-004-0565-y.
The prevalence of the overactive bladder syndrome (OAB) increases with age. Unfortunately, treatment of the condition is still unsatisfactory. Since muscarinic receptor antagonists are the only effective drug treatment to date, it is logical to assume that muscarinic receptors play an important role in the pathogenesis of OAB. Muscarinic receptors are involved in both the normal and overactive detrusor contraction, and age-dependent changes in muscarinic receptor functions have been found in both animals and human detrusors. In animals as well as humans, two components of detrusor contraction have been demonstrated, the dominating one mediated by muscarinic receptors and the other by ATP (atropine-resistant component). The muscarinic receptor-mediated component decreases with age, and the ATP (purinergic) part increases. However, the clinical consequence of this is unclear, since no major age-dependent changes in the efficacy of antimuscarinic agents in the treatment of OAB have been demonstrated.
膀胱过度活动症(OAB)的患病率随年龄增长而增加。遗憾的是,该病的治疗仍不尽人意。由于毒蕈碱受体拮抗剂是迄今为止唯一有效的药物治疗方法,因此可以合理推测毒蕈碱受体在OAB的发病机制中起重要作用。毒蕈碱受体参与正常和过度活跃的逼尿肌收缩,并且在动物和人类逼尿肌中均发现了毒蕈碱受体功能的年龄依赖性变化。在动物和人类中,均已证明逼尿肌收缩有两个组成部分,主要部分由毒蕈碱受体介导,另一部分由ATP介导(阿托品抵抗成分)。毒蕈碱受体介导的部分随年龄增长而减少,而ATP(嘌呤能)部分增加。然而,其临床后果尚不清楚,因为尚未证明抗毒蕈碱药物治疗OAB的疗效有明显的年龄依赖性变化。